Both in Pharmaceuticals
Decoy Therapeutics vs CDT Equity
Over the past year DCOY returned −76.9% and CDT returned −100.0%; their daily moves had a correlation of -0.01.
DCOY −76.9% CDT −100.0%Growth of $1, one year, split-adjusted
| Metric | DCOY | CDT |
|---|---|---|
| Price | $2.13 | $1.45 |
| Market cap | $1.4M | $1.1M |
| Today | −7.79% | −96.95% |
| 1 month | −26.6% | −96.6% |
| 6 months | −68.5% | −99.9% |
| Year to date | — | −100.0% |
| 1 year | — | −100.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | — |
| Net margin | −1042.8% | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $8.3M | -$390.0K |
| Dividend yield | — | — |
| Volatility (60d) | 132.2% | 1,169.4% |
| Short % of float | 0.2% | 34.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).